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Alhasan Najib Elghouche 
MODULATION OF THE NOTCH SIGNALING PATHWAY IN 3D STEM CELL-
DERIVED CULTURE OF INNER EAR ORGANOIDS 
 
Hearing loss and vestibular dysfunction are inner ear disease states that arise from 
an array of diverse etiologies that interfere with mechanosensory hair cell function, 
including: congenital syndromes, noise-induced trauma, ototoxic drugs, and aging. The 
investigation of normal inner ear development and the pathological aberrations that cause 
inner ear disease has been previously advanced through formation of an easily generated, 
scalable, accurate in vitro model system that readily facilitates experimental applications. 
This model utilizes a 3D floating cell culture protocol which guides differentiation of 
stem cell aggregates into inner ear organoids, which are vesicles containing a sensory 
epithelium with functioning mechanosensory hair cells. Inner ear organoid formation 
enables studying the effects of modulating the signaling pathways that guide developing 
inner ear structure and function. The Notch signaling pathway heavily influences the 
formation of the inner ear through two major mechanisms: lateral induction of sensory 
progenitor cells and lateral inhibition to determine which of those progenitors 
differentiate into mechanosensory hair cells. The effects of inhibiting Notch signaling 
within the inner ear organoid system were explored through application of the ɣ-secretase 
inhibitor MDL28170 (MDL) at a concentration of 25µM on day 8 of organoid culture. 
Aggregates were harvested on day 32, fixed, sectioned, and stained according to a 
standard immunohistochemistry protocol. Sections were stained for the mechanosensory 
hair cell markers Myosin7a (Myo7a) and Sox2. MDL-treated aggregates demonstrated 
v 
statistically significant reductions in the total number of vesicles and the number of 
vesicles containing hair cells compared to control aggregates. In contrast to control 
aggregates which demonstrated two distinct organoid variants (protruding and 
embedded), MDL-treated aggregates only formed the embedded variant. Differences in 
the expression pattern of Sox2, which is also a marker of stemness and neural progenitor 
cells were also noted between the two conditions. MDL-treated aggregates demonstrated 
regions of ‘ectopic’ Sox2 expression whereas Sox2 expression in control aggregates was 
consistently expressed within Myo7a+ regions. 
Eri Hashino PhD, Chair
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The mammalian inner ear is an intricate structure containing two sensory 
systems—the cochlea, which detects sound, and the vestibular apparatus, which detects 
positional information. The basic cellular unit of both the auditory and vestibular systems 
is the mechanosensory hair cell which transduces mechanical stimuli from sound or 
positional changes to the brain.1 To enable that function, the inner ear also includes 
neural components and a diverse group of supporting cells. Importantly, mature 
mammalian hair cells are unable to regenerate when damaged; therefore, inner ear 
pathology may elicit irreversible hearing and/or equilibrium deficits. Hearing loss affects 
approximately 1.1 billion individuals across the globe and there is a wide range of 
processes that alter hair cell function including: genetics, medication toxicity, noise-
induced trauma, and aging.2   
The investigation of normal inner ear development and pathological aberrations 
that cause hearing loss or vestibular dysfunction would be enhanced through 
development of an easily generated, scalable, in vitro model system that readily facilitates 
experimental applications. Development of an accurate in vitro model may facilitate: 1) 
high-throughput drug screening for therapeutic or ototoxic compounds, 2) modelling of 
inner ear disease states, and 3) investigation of various cell, gene, and pharmacologic 
therapies for hearing loss and vestibular dysfunction.3  
Through in vitro application of proteins and small molecules at precise time 
points, embryonic stem cells (ESCs)  can be driven to differentiate into three-dimensional 
(3D) inner ear organoids.4,5 During the differentiation process are correlates to specific 
stages and components of inner ear development including the nonneural ectoderm, otic 
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placode, and otocyst. The 3D inner ear organoids contain vesicles lined by an epithelium 
containing all compnents of the inner ear: hair cells, supporting cells, and sensory 
neurons.4,5 These sensory organoids may form in one of two variants—protruding 
organoids which project from the surface of the aggregate and organoids which remain 
embedded within the surface of the aggregate. 
Organogenesis is increasingly being studied in the context of 3D floating cell 
culture which facilitates self-organization of cells into complex organ-like structures,6-9 
as opposed to traditional monolayer culture which restricts 3D arrangement of cells.10 3D 
culture more closely models physiologic embryogenesis and allows increased freedom 
for morphologic changes (e.g. invagination and vesicle formation) and the spatial 
relationships and intricate signaling gradients within developing tissue.10,11 The complex 
interactions of the various signaling pathways which play out during embryogenesis are 
better replicated in three dimensions; during inner ear development, one such signaling 
paradigm that is particularly influential is the Notch pathway.12,13 Notch signaling 
contributes to important developmental phenomena including cell fate specification, 
proliferation, and boundary formation.14,15 
Notch signaling mediates two important processes during inner ear development: 
1) definition of prosensory domains which ultimately form the sensory epithelia and 2) 
establishment of the mosaic pattern of mechanosensory and supporting cells within those 
epithelia.12,16 These two processes are respectively mediated through the mechanisms of 
lateral induction and lateral inhibition. Different Notch ligands at different time points in 
development characterize the two processes. 
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Specification and expansion of the prosensory domain defined by the otic placode 
is mediated by lateral induction.16-19 This region contains the sensory progenitor cells 
which go on to become either mechanosensory hair cells or supporting cells within the 
sensory epithelium. Studies in both chick and mouse demonstrate expression of the Notch 
ligand Jag1 before and during emergence of sensory progenitor cells.18,20,21 Furthermore, 
Jag1 is a recognized marker of otic prosensory cells and Notch activation elicits further 
Jag1 upregulation.13,19,21,22 Expression of Jag1 activates the Notch receptor in adjacent 
cells and programs them to become sensory progenitors as well.20 Indeed, loss of Jag1 
function causes attenuation of sensory progenitor regions within the mouse embryo.22 
Conversely, overexpression of the activated Notch receptor induces ectopic regions of 
mechanosensory hair cells and supporting cells within the inner ear, further suggesting an 
important role for the Notch pathway in otic specification.22 Conditional deletion of Jag1 
has been shown to downregulate the prosensory marker Sox2 and results in malformation 
of the cochlea with reductions in the number of hair cells and supporting cells.17,23 Jag1 is 
known to be expressed in the vesicles which arise during 3D inner ear organoid 
formation.4 
Following specification of sensory progenitor cells, the well-characterized Notch 
mechanism of lateral inhibition takes place.18,24 Lateral inhibition describes a process 
whereby expression of specific ligands by a cell destined for a particular fate prevents 
neighboring cells from pursuing the same fate.25 In the developing inner ear, 
differentiating hair cells express Notch ligands Delta1 and/or Jag2 and thereby activate 
the Notch pathway in adjacent cells. Activation by either of these ligands causes 
upregulation of effectors Hes1 and Hes5 and subsequent attenuation of Atoh1 
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expression—because Atoh1 is required for sensory hair cell differentiation, Atoh1 
inhibition in cells adjacent to future hair cells causes the mosaic patterning of the otic 
sensory epithelium.20,26,27 Consistent with this concept of lateral inhibition, mice lacking 
Delta1 or Jag2 demonstrate supernumerary hair cell formation.20,28 
In sum, Notch-mediated lateral signaling among neighboring cells initially 
expands the number of sensory progenitor cells through lateral induction and then limits 
which sensory progenitors can differentiate into mechanosensory hair cells. Therefore, 
attenuation of Notch-mediated lateral induction may be expected to reduce the yield of 
inner ear organoids within the 3D culture system. Conversely, attenuation of Notch-
mediated lateral inhibition may augment the yield of inner ear organoids.  
Activation of a Notch receptor causes enzymatic cleavage of the intracellular 
domain of the receptor. This cleavage is mediated via the ɣ-secretase enzyme, so Notch 
signaling may be blocked by ɣ-secretase inhibitors such as DAPT and MDL28170 
(MDL).29 Given the established and influential role of Notch signaling in both sensory 
specification and hair cell differentiation both in vivo and in vitro, the effects of 







Research Design and Results 
The research design encompassed the otic differentiation protocol described by 
Koehler and Hashino using Atoh1-eGFP mouse embryonic stem cells (ESCs) maintained 
in leukemia inhibitory factor (LIF) medium to prevent spontaneous differentiation.4,5 In 
this protocol, ESCs are dissociated and arranged in floating aggregates of approximately 
3,000 cells per each well of a 96-well U-bottom plate. Through the application of specific 
media, extracellular matrix components, small molecules and proteins at precise time 
points over the next four days followed by transfer to a 24-well plate on day 8 for self-
guided organization, aggregates undergo differentiation and develop to contain vesicles 
with functioning vestibular hair cells (termed “inner ear organoids”).4,5 In the present 
experiment, samples were allocated to treatment either with control media or media 
infiltrated with a ɣ-secretase inhibitor at a specific time point.  
Of note, the majority of aggregates treated on day 8 with the inhibitor DAPT at a 
concentration of 10µM demonstrated disaggregation with presence of floating cellular 
debris. Based on this observation, and that control specimens maintained under otherwise 
identical conditions did not demonstrated cellular death, treatment with DAPT at this 
concentration was deemed toxic to the aggregates.  
The following data was generated from an experiment in which approximately 
half of the wells in a 96-well plate were designated for “control” aggregates and treated 
according to the standard otic differentiation protocol. The remaining aggregates were 
treated with MDL on day 8 at a final concentration of 25µM. This concentration was 
determined based on the best available data from prior explant studies, differentiation 
attempts, and absence of grossly toxic effects on aggregates.29  Control and MDL-treated 
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aggregates were then maintained under identical conditions with media changes 
occurring every two days and underwent routine imaging under light microscopy to 
monitor their progression. Under light microscopy, control aggregates demonstrated 
higher proportions of Atoh1+ vesicles (Figure 1). On day 32, all aggregates were 
collected and fixed in paraformaldehyde solution prior to being embedded in cryomedia. 
Aggregates were then sectioned via cryostat in their entirety and mounted onto slides for 
immunohistochemical staining. Following incubation of slides with a blocking buffer, 
staining was performed utilizing primary antibodies against the hair cell marker Myosin 
VIIa (Myo7a, Proteus Biosciences Inc.) and the sensory epithelium marker Sox2 (BD 
Biosciences) diluted to ratios of 1:100. Secondary fluorophore-containing antibodies 
directed against each type of primary antibody were then applied. Coverslips were 
affixed to each slide and microscopy was subsequently performed. Each section was 
analyzed microscopically to determine the total number of vesicles within that section 
and the number of vesicles which contained hair cells, determined by positive 
immunofluorescence for the markers Myo7a and Sox2. A total of 362 sections were 
generated and analyzed from control aggregates and a total of 322 sections were 
generated and analyzed from MDL-treated aggregates. 
The average number of vesicles per section (Figure 2) was 1.20 for control 
aggregates compared to 0.32 for MDL-treated aggregates (p<.001). Not all vesicles 
which form within the aggregates contain hair cells (Figure3). The average number of 
hair cell-containing vesicles per section (Figure 4) was 0.24 for control aggregates 
compared to 0.05 for MDL-treated aggregates (p<.001). The average proportion of 
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vesicles that were positive for hair cells within each section (Figure 5) did not differ 
significantly between control aggregates and those treated with MDL. 
No sections from the MDL-treated aggregates demonstrated the “protruding” 
organoid variant, whereas sections from control aggregates demonstrated both 
“protruding” and “embedded” variants (Figures 6 & 7). Sox2 expression in control 
aggregates was primarily co-localized with Myo7a; MDL-treated aggregates however 
consistently demonstrated scattered Sox2 expression outside of Myo7a+Sox2+ vesicles 















Initial research design involved a coordinated set of dose-response experiments 
for three separate inhibitors applied once at varying time points to determine the precise 
concentration, time point, and ɣ-secretase inhibitor that would elicit increased yield of 
hair cells within the differentiation protocol. This design was planned based upon prior 
studies documenting the effects of Notch inhibition on otic sensory epithelia. Aggregates 
treated with the Notch inhibitor MDL28170 on day 8 demonstrated a significantly lower 
number of vesicles and a resulting lower number of hair cell-containing vesicles 
compared to controls. These findings are consistent with previous studies of Notch 
signaling in the developing inner ear.  
It has been noted that Notch1 receptor activation within the Pax2+ region destined 
to become the otic placode causes expansion of otic placode markers.30 The otic placode 
is one of various cranial placodes, which are thickened patches of ectoderm that develop 
into the sensory cells, neurons, and support cells of the cranial sense organs.31-33 In the 
otic differentiation protocol utilized, expression of the transcription factor Pax2 is noted 
between day 8 and day 12. The relatively early inhibition of Notch signaling at day 8 
potentially impaired expansion of sensory progenitors in the Pax2+ otic placode through 
interference with the process of lateral induction. 
In addition to lateral induction, Notch signaling contributes to the size of the 
developing otic placode through augmentation of the Wnt signaling pathway.30 In mice, 
specification of the otic placode is mediated by expression of Wnt ligands including 
Wnt8a from the caudal hindbrain.34-36  The role of Wnt signaling in otic specification is 
further supported by mouse studies in which deletion of β-catenin reduces the size of the 
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otic placode.37 It has previously been shown that aggregates treated with a Wnt inhibitor 
display impaired vesicle production, indicating involvement of endogenous Wnt 
signaling in the formation of otic vesicles.4 Based on the high degree of overlap among 
the Notch and Wnt pathways, the results described above suggest interference with 
endogenous Wnt signaling within MDL-treated aggregates and subsequently impaired 
otic vesicle formation. 
Protruding organoids are typically present in approximately 15% of aggregates 
developed under original protocol conditions.4 It has been postulated that Pax2 
contributes to the thickened pseudostratified morphology of the otic placode and resultant 
expression of cellular adhesion molecules, facilitating placode invagination and 
formation of the otic vesicle.38,39 Therefore a reduction in Pax2 expression and otic 
placode size in MDL-treated aggregates may also account for the complete absence of 
protruding vesicles. 
In sum, application of MDL28170 on day 8 of the otic differentiation protocol 
potentially impaired organoid development by: 1) attenuating Notch-mediated lateral 
induction of sensory progenitors, 2) preventing Notch augmentation of Wnt-driven otic 
placode expansion, and 3) attenuation of the Pax2+ region capable of invagination and 
otic vesicle formation. These results indicate the presence of endogenous Notch signaling 
within the aggregates and its influence on formation of inner ear organoids. Thus far the 
effects of Notch inhibition on inner ear organoid development correlate with in vivo 
embryogenesis and thereby further validate this novel model system. 
Further investigation is required to determine the cause and significance of the 
different patterns of Sox2 expression seen between control and MDL-treated aggregates. 
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Within the inner ear, Sox2 is initially expressed throughout the prosensory epithelium 
and later localized to fully differentiated supporting cells.12 Sox2 is also known to be 
involved in maintenance of pluripotency within embryonic and neural stem cells.40 Given 
that undifferentiated ESCs have been shown to express Notch receptors and ligands, it is 
possible that Notch inhibition affected the differentiation of certain cells within the 
aggregates and retained them in a progenitor state.41 Further immunohistochemical 
analyses may be helpful to further characterize the nature of the ectopic patches of Sox2 
found in MDL-treated aggregates; for example, positive staining for β-Tubulin 3 would 
be consistent with nests of neural progenitor cells.  
Future studies should continue use of MDL28170 concentrations near 25µM, 
which is efficacious based on the significant differences between control and MDL-
treated aggregates. Comparison with other concentrations may be useful to establish 
dose-response relationships and further validate the effects of Notch inhibition. Earlier 
endpoint analysis will be useful to confirm and further analyze the effects of Notch 
inhibition on the developing otic placode. One potential extension of this data is 
application of Notch agonists at day 8 to determine if this augments vesicle formation and 
permits formation of protruding inner ear organoids. The ultimate goal for increased hair 
cell yield via Notch inhibition is predicated on interference with the process of lateral 
inhibition and not lateral induction. The above data suggest that at day 8, the region 
destined to become the sensory epithelium is undergoing lateral induction of sensory 
progenitor cells and Notch inhibition at this time point has a negative effect on organoid 
development. This indicates that treatment with a Notch inhibitor at a later time point is 
likely necessary to attenuate Notch-mediated lateral inhibition and increase the yield of 
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hair cells within the inner ear organoids. This later time point is likely between day 8 and 
day 14, when fully differentiated hair cells are noted within the organoids.  
Quantification of the precise timeline, via real-time polymerase chain reaction, at 
which specific Notch ligands (i.e. Jag1 versus Jag2 and Delta1) are expressed may 
provide further insight into the precise time points to inhibit Notch signaling in order to 
augment the yield of organoids and hair cells generated in the 3D culture protocol.  


























































Figure 1. Inner ear organoids may be visible in aggregates floating in 3D 
culture. A) DIC image of day 30 aggregate with vesicle. B) Image of same 
aggregate demonstrating GFP expression within vesicle indicating presence 
of Atoh1+ hair cells.  C) Overlay of GFP expression and DIC image. D) At 
day 18, over 50% of control aggregates displayed Atoh1+ vesicles by light 
microscopy as compared to 11% of MDL-treated aggregates (n= 24 
aggregates per condition). 
Figure 2. The mean number of all types of vesicles (those containing 
hair cells and those not containing hair cells) per section was 
significantly lower in aggregates treated with the Notch inhibitor 
MDL28170 (p<.001). 
























	   	  
	   	  




Figure 4. The mean number of vesicles 
containing hair cell cells was significantly 
lower in aggregates treated with the Notch 






























Figure 3. Immunohistochemistry of a control aggregate demonstrating 
vesicles which do not (arrows) and do (arrowhead) contain Myo7a+Sox2+ 
hair cells. 
10x 
DAPI Sox2 Myo7a Merge 
20x 
14 
Figure 5. The mean proportion of vesicles in 
each section that contained hair cells did not 
differ significantly between conditions 
(p=.37). 
Figure 6. Immunohistochemistry of a control aggregate 
demonstrating the simultaneous presence of both inner ear 














































Figure 7. In contrast to control aggregates, MDL-treated 












































Figure 8. Sox2 expression within control aggregates was primarily 
co-localized with cells positive for Myo7a. In contrast, MDL-treated 
aggregates demonstrated scattered ‘ectopic’ regions of Sox2 




















	   	  























Figure 9. Representative images from two separate MDL-
treated aggregates demonstrating scattered ‘ectopic’ regions of 
Sox2 expression in addition to co-expression with Myo7a 
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o Dean-appointed position to faculty committee which decides the academic 
standing of medical students. Responsibilities included hearing individual 
cases of medical students not in good academic standing and making 
decisions regarding dismissal or remedial action. 
§ IUSM OSCEs, Evaluator (2015 Jun—2015 Dec) 
o Appointed by Student Assessment Office to grade objective structured 
clinical examinations (OSCEs) of medical students following completion 
of their clerkships and also at the culmination of their third year. 
§ Wheeler Mission Clinic, Volunteer (2014 Mar—2015 Sep) 
o Care for homeless population of Indianapolis involving interviewing and 
examining patients, formulating plans, writing prescriptions, and arranging 
follow-up. 
§ Student Outreach Clinic, Volunteer (2014 Mar—2015 Aug) 
o Volunteer work in a student-run clinic.  Responsibilities included care for 
patients, collecting laboratory samples, writing prescriptions, and 
arranging follow-up. 
§ United Kingdom Medical Student Association, Author (2015 May—2015 Aug) 
o Research and composition of articles for United Kingdom Medical 
Student Association Handbook, a reference text on a range of clinical 
topics aimed at medical students. Articles published in online handbook 
and mobile application. 
§ Institute for Healthcare Improvement IUPUI Chapter, President (2014 Jul—2015 
Jul) 
	  o Leader of newly established chapter of Institute for Healthcare at Indiana 
University Purdue University Indianapolis. Inter-professional group 
focused on increasing awareness about quality improvement and 
improving patient care. Worked to increase membership and incorporate 
patient safety and quality improvement concepts into medical curriculum. 
§ IUSM Gross Anatomy Course, Teaching Assistant (2014 Nov—2014 Dec) 
o Teaching assistant for head & neck portion of first year anatomy course 
(lecture and laboratory portions) at the Indiana University School of 
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